Seminar Invitation: Pitfalls for SMEs in protecting and claiming incentives for new developments

Presented by:

  • Joe Seisdedos (Wrays)Wrays
  • Bill Charlton (UHY Haines Norton)
  • Michael Oon (Swanson Reed)

Join Swanson Reed, UHY Haines Norton and Wrays for a practical workshop that will focus on the problems that every day companies face in protecting, and claiming incentives for their new products.

You will hear from three industry experts on a range of topics, including tax issues, R&D tax incentives and patent protection.

On conclusion of the presentation, participants will have an opportunity to ask the panel any specific questions in a friendly and constructive forum.

 

Time Presentation Presenter
7:00am – 7:30am: Session 1: Protecting Intellectual Property (IP) Joe Seisdedos
7:30am – 8:00am: Session 2: IP & Relevant Tax Considerations Bill Charlton
8:00am – 8:30am: Session 3: R&D Tax Incentives Michael Oon
8:30am – 9:00am: Session 4: Panel Q&A and Networking Opportunity

 

Joe Seisdedos Bill Charlton Michael Oon
Joe_seisdedos Bill-Charlton Michael-Oon
 View Joe’s bio  View Bill’s bio  View Michael’s bio

Brisbane R&D Tax Seminar:


View Larger Map

Wednesday, 18th June 2014
7am – 9am
Swanson Reed Boardroom
Level 11, 42-60 Albert St
Brisbane, 4000

Cost: Free!
Register Before:
 Friday 13th June

Register your interest

Full attendance at this workshop will yield 2 CPE hours towards the Tax Practitioners Board’s (TPB) CPE requirements.

Contact Amy Nolan for more information:

Ph: 07 3221 1499
Mob: 0435 713 493

Are you Eligible to claim R&D? Take our R&D Eligibility Survey and find out.

Latest News

Fintech Australia Submission Discusses Application of R&D Tax Incentive to Software

InnovationAus this week has reported on concerns raised by advocacy group Fintech Australia in respect of the application of the R&D Tax Incentive to software activity. The concerns were raised in the group’s submission to the Select Committee on Australia as a Technology and Financial Centre, and a summary of points raised include: concern that regulators’ interpretations of “activities” and “experiments” under the scheme are restrictive to software claims and lead to many tech firms not accessing the incentive; concern that […]

Government Discussion Paper and Consultation on Patent Box for Medical and Biotechnology Sectors

In the May federal budget, the Australian Government announced that it will introduce a patent box for eligible income associated with new patents in the medical and biotechnology sectors. The patent box will apply to companies for income years commencing on or after 1 July 2022, and for new Australian patents since budget night.   The aim of such a policy is to encourage companies to base their medical and biotechnology R&D activity in Australia and to retain associated patent […]

    Email this job